South Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,770
| Closed | -$1.12M | – | 75 |
|
|
2023
Q4 | $1.12M | Sell |
21,770
-1,315
| -6% | -$69K | 0.21% | 47 |
|
|
2023
Q3 | $1.34M | Hold |
23,085
| – | – | 0.27% | 45 |
|
|
2023
Q2 | $1.48M | Sell |
23,085
-5,420
| -19% | -$363K | 0.29% | 44 |
|
|
2023
Q1 | $1.98M | Hold |
28,505
| – | – | 0.41% | 40 |
|
|
2022
Q4 | $2.05M | Hold |
28,505
| – | – | 0.45% | 39 |
|
|
2022
Q3 | $2.03M | Hold |
28,505
| – | – | 0.5% | 39 |
|
|
2022
Q2 | $2.19M | Hold |
28,505
| – | – | 0.5% | 38 |
|
|
2022
Q1 | $2.08M | Sell |
28,505
-380
| -1% | -$25.5K | 0.39% | 41 |
|
|
2021
Q4 | $1.8M | Sell |
28,885
-2,800
| -9% | -$164K | 0.32% | 41 |
|
|
2021
Q3 | $1.88M | Hold |
31,685
| – | – | 0.36% | 41 |
|
|
2021
Q2 | $2.12M | Buy |
+31,685
| New | +$2.07M | 0.39% | 36 |
|
|
2021
Q1 | – | Sell |
-238,665
| Closed | -$14.8M | – | 36 |
|
|
2020
Q4 | $14.8M | Buy |
238,665
+2,670
| +1% | +$164K | 3.14% | 21 |
|
|
2020
Q3 | $14.2M | Buy |
235,995
+28,000
| +13% | +$1.69M | 3.44% | 15 |
|
|
2020
Q2 | $12.2M | Buy |
+207,995
| New | +$12.4M | 3.27% | 17 |
|
|
2020
Q1 | – | Sell |
-3,270
| Closed | -$210K | – | 56 |
|
|
2019
Q4 | $210K | Buy |
+3,270
| New | +$187K | 0.05% | 66 |
|
|
2018
Q4 | – | Sell |
-3,360
| Closed | -$208 | – | 63 |
|
|
2018
Q3 | $208 | Buy |
+3,360
| New | +$199K | 0.03% | 67 |
|
|
2018
Q2 | – | Sell |
-3,540
| Closed | -$223 | – | 62 |
|
|
2018
Q1 | $223 | Hold |
3,540
| – | – | 0.02% | 60 |
|
|
2017
Q4 | $216K | Sell |
3,540
-80
| -2% | -$5K | 0.07% | 60 |
|
|
2017
Q3 | $230 | Hold |
3,620
| – | – | 0.04% | 56 |
|
|
2017
Q2 | $201K | Buy |
+3,620
| New | +$197K | 0.07% | 65 |
|
|
2016
Q4 | – | Sell |
-4,355
| Closed | -$234K | – | 61 |
|
|
2016
Q3 | $234K | Sell |
4,355
-70
| -2% | -$4.5K | 0.07% | 56 |
|
|
2016
Q2 | $325K | Hold |
4,425
| – | – | 0.1% | 49 |
|
|
2016
Q1 | $282K | Hold |
4,425
| – | – | 0.09% | 49 |
|
|
2015
Q4 | $304K | Hold |
4,425
| – | – | 0.1% | 49 |
|
|
2015
Q3 | $261K | Sell |
4,425
-645
| -13% | -$40.9K | 0.09% | 54 |
|
|
2015
Q2 | $337K | Hold |
5,070
| – | – | 0.11% | 48 |
|
|
2015
Q1 | $327 | Buy |
+5,070
| New | +$317K | 0.1% | 53 |
|
Other funds holding BMY
South Street Advisors's BMY Position: Q1 2024 in Review
South Street Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 21,770 shares — an estimated $1.12M sold.
South Street Advisors first reported a position in BMY in Q1 2015 and held it in 27 quarters. The position peaked at $14.8M in Q4 2020. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- South Street Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- South Street Advisors sold 21,770 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.12M.
- South Street Advisors first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 27 quarters.
- South Street Advisors's Bristol-Myers Squibb position peaked at $14.8M in Q4 2020.
- 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on South Street Advisors's 13F filing for Q1 2024, filed 10 May 2024.